OpenAI Acquires Orchestra Bio in Life Sciences Expansion
OpenAI acquired Orchestra Bio, a platform that helps biopharma teams use AI agents to coordinate drug development. Orchestra’s team will coordinate with OpenAI’s AI models, including Rosalind.
OpenAI has acquired Orchestra Bio, a platform that helps biopharma teams use AI agents to coordinate drug development. The acquisition comes as OpenAI expands further into life sciences. Orchestra’s team will work with Rosalind, OpenAI’s AI models…